Blachford | Contract Pharma

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Blachford | Contract Pharma

Search by

Blachford

Company Headquarters

2323 Royal Windsor Drive , Mississauga, ON, L5J 1K6, CA

Driving Directions Phone: View Phone Fax: View Fax

View website

Request more information from Blachford

Request more information from Blachford

Yes, Please subscribe me to your weekly eNewsletters and Alerts

Yes, I wish to receive special promotions and offers from your affiliates.

Yes, I would like to learn more about Blachford. Please contact me by Phone or Email

By completing this form, you are accepting our Terms of Use and Privacy Policy.

Categories from Blachford

Chemicals and Raw Materials

Excipients

Supplier, Excipients

Supplier, Raw Materials

Related Content

Gattefossé,

Breaking News

Gattefossé Accelerates Production Ramp-up at Lufkin Facility

Three pharmaceutical excipients now manufactured in Texas include Peceol, Compritol 888, and Geleol Mono and Diglycerides NF.

By: Kristin Brooks

Breaking News

BASF Announces Up to 20% Price Increase for Excipients and APIs

Cites rising global energy and raw material costs.

By: Charlie Sternberg

928627237658790___260116BeyondtheCapsulePrimaryImage840x454

White Papers / Tech Papers

Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms

How established lipid chemistries offer a safe, scalable approach to accelerate your next tablet formulation to market

Released By Gattefossé USA

USP_Webinar_Web_Ad_840 x 454

Sponsored Content

Strengthening Polymeric Excipient Quality in LAIs: The USP Approach

On February 10, USP experts take a deep dive into standards and solutions that support quality and performance across the drug lifecycle

Released By U.S. Pharmacopeia (USP)

USP_Webinar_Web_Ad_840 x 454

Strengthening Polymeric Excipient Quality in LAIs: The USP Approach

Lubrizol Q&A

Pharma Matters Q&A

Overcoming Formulation Complexity with Advanced Excipients

Liliana Miinea of Lubrizol Pharmaceuticals R&D shares insight on challenges drug developers face and solutions for today’s complex drug products.

Released By Lubrizol Life Science Health

Ashland High Purity Sugar Excipients

Breaking News

Ashland Expands Portfolio of High Purity Sugar Excipients

Adds high purity sucrose to injectables portfolio, and highlights low nitrite pharmaceutical excipients.

By: Kristin Brooks

Asahi Kasei excipient

Breaking News

Asahi Kasei Launches Sonanos Next-Gen Excipients

Aims to address formulation, drug persistence, and delivery challenges by enabling sustained release and enhanced solubility.

By: Kristin Brooks

Pharma_Matters_gChem_Graphics_840 x 454

Pharma Matters Q&A

Rewriting the Rules of DMSO

gChem’s Rishi Pimentel on pharma-grade solvents, regulatory-ready excipients, and the power behind Procipient®.

Released By gChem

Lipid Excipients in Oral Solid Dosage Forms

Sponsored Content

Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms

This presentation highlights emerging research and formulation strategies that expand the use of lipid excipients in oral tablet development.

Released By Gattefossé USA

Lipid Excipients in Oral Solid Dosage Forms

Beyond the Capsule: Unlocking the Full Potential of Lipid Excipients in Oral Solid Dosage Forms

evonik maxipure

Breaking News

Evonik Launches MaxiPure Polysorbate 80

Excipient addresses key challenges such as protein stability, viral inactivation, and the consistent solubilization of hydrophobic APIs.

By: Charlie Sternberg

roquette pills

Breaking News

Roquette Launches POLYOX Extended Stability Packaging

Is designed to advance excipient stability and sustainability.

By: Charlie Sternberg

Untitled design-50

Breaking News

Nucleus Biologics Achieves EXCiPACT Certification

Excipient GMP certification validates the company's quality systems and process controls to support the cell and gene therapy sectors.

By: Kristin Brooks

761_main

Breaking News

Evonik Opens New Facility in Darmstadt

The new excipient manufacturing facility enables Evonik to meet the increasing demand from pharmaceutical customers for oral drug delivery solutions.